Report on Worldwide Clinical Trials Market 2009-2024

HTML clipboardThis report provides detailed sales forecasts,
Clinical Trials: World Market 2009-2024discussions of pipeline developments and analyses of
The market for clinical trials has been expandingcommercial drivers and restraints, including a SWOT
rapidly in recent years, with impressive revenueanalysis. There are many tables and figures and two
growth and important trends. One regional marketfull interviews with experts in the sector. The result is
expanded by 65% in 2008. From the perspectives ofa comprehensive market- and industry-centred
various pharma stakeholders, the expanding clinicalreport, with detailed analyses and informed opinion to
research market represents opportunities forbenefit your work.
revenue growth and cost savings. Our latest report -Why you should buy Clinical Trials: World Market
Clinical Trials: World Market 2009-2024 - considers2009-2024
perspectives of pharma companies and CROs inOur new report provides you with the following
particular. We comprehensively analyse thebenefits:
market’s strengths, weaknesses and revenue• Instant access to hard-to-find revenue
trends from 2009 to 2024. ( )forecasts for the clinical trials market from 2009 to
This report provides hard-to-find data on the current2024
and future value of clinical trials markets, both• An analysis of regional developments and how
worldwide and regionally. Importantly, this reportrevenues and market shares will change from 2009
covers emerging markets, highlighting salient trendsto 2024
there. Our report addresses regional questions. For• Comprehensive quantitative and qualitative
example, how will India’s market share changeanalyses of how the clinical trials market will develop
between now and 2024? Will the Central and Easternfrom 2009, and why
European market expand more quickly than the• A comprehensive assessment of the worldwide
market in China? We also address global questions,market for CROs
such as: what proportion of the sector will be• An easily-accessible review of clinical trials
controlled by contract research organisations in theregulations, procedures and essential market
future? CROs are playing increasingly important rolesinformation
in drug development worldwide, from conducting• Insight into market drivers and restraints for the
phase I trials to post-marketing studies.global clinical trials market in the shorter and longer
Clinical Trials: World Market 2009-2024 is now in itsterm, including SWOT analysis
third edition. This 2009 edition is re-written, with• Analytical reviews of important CROs and
all-new analyses. It takes into account the changedservices they offer
economic environment, as well as developments in• Full transcripts of original interviews with Dr
policy, technology and the market.Nathaniel Katz of Analgesic Research, discussing
Comprehensive analysis of the clinical trials marketpatient recruitment, and with Dr Kevin Dykstra of
Clinical Trials: World Market 2009-2024 examines thatPharsight, discussing the future of adaptive trials
sector critically, through a comprehensive review of• All the information you need to assess the
information sources, both primary and secondary.market’s potential from the present onwards.